Selects WSSC Water to Pilot Innovative Technology to Enhance Employee Safety
WASHINGTON, March 15, 2021, /3BL Media/ - IBM (NYSE: IBM) today announced that it has been awarded the second phase of the Digital Health Solutions for COVID-19 contract by the National Institutes of Health (NIH) to continue its work to develop and implement digital health solutions that are designed to help address the COVID-19 pandemic in an effort to help reopen public places.
This profile is a part of the Amgen Foundation’s “Meet the Scientists” series, where we invite students and teachers to learn more about a scientist at Amgen and the work they do to create lifesaving medicines. Join the conversation by sharing your own experiences with @AmgenFoundation and @Amgen.
When Cameron Clarke was first assigned a policy brief as an Amgen Scholar at the National Institutes of Health (NIH) in 2016, it was the start of something big: a career in public health policy. In the year that followed, he would use the policy brief writing skills again and again as an intern on Capitol Hill, and then with several local government organizations on issues ranging from opioid addiction and minority health inequities to environmental policy.
“Any time you build a connection with someone in your field, or a field you’re interested in, that’s networking,” says Isabelle Rosenthal, reflecting on what she has learned about networking since attending the Amgen Scholars U.S. Symposium at UCLA in 2015. Rosenthal, now a lab manager at the National Eye Institute at the National Institutes of Health (NIH), graduated from Wellesley College with a degree in neuroscience in 2016. She is now studying how humans perceive color.
This summer, 1,100 student interns will be living, studying, and working on the sprawling campus of the National Institutes of Health (NIH) in Bethesda, MD, just north of Washington, D.C. Among them will be five Amgen Scholar alumni who will serve as mentors to some of the high school student interns in a unique pilot program to teach scientists how to be educators.
"It was absolutely amazing to be able to speak with experienced researchers at the symposium about the science, and career paths in science. Attending the symposium helped confirmed my decision to pursue a career in academic medicine."
Host University: National Institutes of Health
Home University: Harvard University
Amgen Scholar Year: 2016
Major: Human and Developmental Regenerative Biology
PARIS, July 12, 2016 /3BL Media/ - Sanofi and its vaccines global business unit Sanofi Pasteur announced today a Cooperative Research and Development Agreement with the Walter Reed Army Institute of Research (WRAIR) on the co-development of a Zika vaccine candidate. According to the terms of the agreement, WRAIR will transfer its Zika purified inactivated virus (ZPIV) vaccine technology to Sanofi Pasteur, opening the door for a broader collaboration with the U.S. government.